ENCOMPASS PREECLAMPSIA SCREEN Trademark

Trademark Overview

On Wednesday, August 17, 2022, a trademark application was filed for ENCOMPASS PREECLAMPSIA SCREEN with the United States Patent and Trademark Office. The USPTO has given the ENCOMPASS PREECLAMPSIA SCREEN trademark a serial number of 97552029. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 21, 2025. This trademark is owned by Mirvie, Inc.. The ENCOMPASS PREECLAMPSIA SCREEN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes

General Information

Serial Number97552029
Word MarkENCOMPASS PREECLAMPSIA SCREEN
Filing DateWednesday, August 17, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes
NOT AVAILABLE"PREECLAMPSIA SCREEN"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMirvie, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameMirvie, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, June 15, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, August 20, 2022NEW APPLICATION ENTERED
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 2, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 15, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 18, 2024SOU EXTENSION 1 GRANTED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 18, 2024SOU EXTENSION 1 FILED
Thursday, September 19, 2024SOU EXTENSION 2 FILED
Monday, October 21, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 21, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, October 29, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 29, 2024PETITION TO REVIVE-GRANTED
Tuesday, October 29, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, October 29, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, January 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 28, 2025SOU EXTENSION 2 GRANTED
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 21, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, April 21, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

screen preeclampsia encompass purposes treatment diagnostic testing medical